Granulosa cells from immature hypophysectomized diethylstilbestrol-treated rats displayed pronounced intracellular and intercellular changes after 48 hr of exposure to follicle-stimulating hormone (FSH) in vitro. As determined by light and electron microscopy, most of the FSH-treated cells became highly aggregated and grew in multilayered clusters. Numerous gap junctions were seen between cells...

Summary Statements1.The particular follicle-stimulating hormone formulation used for ovarian stimulation does not affect the incidence of hyperstimulation syndrome. (I)2.Coasting may reduce severe (III)3.Coasting longer than 3 days reduces in vitro fertilization pregnancy rates. (II-2)4.The use either luteinizing or human chorionic gonadotropin final oocyte maturation influence (I)5.There is no...

Background Ovarian hyperstimulation syndrome (OHSS) is an iatrogenic complication, which can cause high morbidity and mortality. Use of gonadotropin releasing hormone (GnRH) agonist instead of human chorionic gonadotropin (hCG) in GnRH antagonist cycles causes luteinizing hormone surge by GnRH stimulation which reduces the risk of OHSS by reducing the total amount of gonadotropin; however, ther...

until 2000 it was believed that gonadotropin-releasing hormone (gnrh) was the sole regulator of hypophyseal gonadotropes. in 2000, the discovery of a gonadotropin inhibitory hormone (gnih) initiated a revolution in the field of reproductive physiology. identification of gnih homologues in mammals, the arginine-phenylalanine- amide (rfamide)-related peptides (rfrps), indicated a similar function...